Comparative investigation of kidney mesangial cells from increased oxidative stress-induced diabetic rats by using different microscopy techniques

Molecular and Cellular Biochemistry

Volumn 390, Issue 1-2, 2014, Pages 41-49

  Sargin, Ayse Kose ^a   Can, Belgin ^a   Turan, Belma ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Antioxidant defense; Diabetes; Kidney; Mesangial cells; Oxidative stress

Indexed keywords

ANIMAL; DIABETIC NEPHROPATHY; EXPERIMENTAL DIABETES MELLITUS; MALE; MESANGIUM; MESANGIUM CELL; MICROSCOPY; OXIDATIVE STRESS; PATHOLOGY; PROCEDURES; RAT; ULTRASTRUCTURE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GLOMERULAR MESANGIUM; MALE; MESANGIAL CELLS; MICROSCOPY; OXIDATIVE STRESS; RATS;

EID: 84898856843     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1953-7     Document Type: Article

References (45)

1. Bader R, Bader H, Grund KE, Markensen S, Christ H, Bohle A (1980) Structure and function of the kidney in diabetic glomerulosclerosis: correlations between morphologic and functional parameters. Pathol Res Pract 167:204-216
2. Ziyadeh FN, Simmons DA, Snopes ER, Goldfarb S (1991) Effect of Myo-inositol on cell proliferation and collagen transcription in proximal tubule cells cultured in elevated glucose. J Am Soc Nephrol 1:1220-1229
3. Kakizawa H, Itoh M, Itoh Y, Imamura S, Ishiwata Y, Matsumoto T, Yamamoto K, Kato T, Ono Y, Nagata M, Hayakawa N, Suzuki A, Goto Y, Oda N (2004) The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. Metabolism 53(5):550-555
4. Feener EP, King GL (2001) Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. Heart Fail Monit 1(3):74-82
5. Spitaler MM, Graier WF (2002) Vascular targets of redox signalling in diabetes mellitus. Diabetologia 45(4):476-494
6. Khan ZA, Chakrabati S (2003) Growth factors in proliferative diabetic retinopathy. Exp Diabesity Res 4:287-301
7. Dogra G, Rich L, Stanton K, Watts GF (2001) Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia 44(5):593-601
8. Kamata K, Miyata N, Kasuya Y (1989) Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 249(3):890-894
9. Zeydanli EN, Turan B (2009) Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aorta. Can J Physiol Pharmacol 87(12):1063-1073
10. Zeydanli EN, Bilginoglu A, Tanriverdi E, Gurdal H, Turan B (2010) Selenium restores defective beta-adrenergic receptor response of thoracic aorta in diabetic rats. Mol Cell Biochem 338(1-2):191-201
11. Zeydanli EN, Kandilci HB, Turan B (2011) Doxycycline ameliorates diabetic vascular endothelial and contractile dysfunction in thoracic aorta. Cardiovasc Toxicol 11(2):134-147
12. Dollery CM, McEwan JR, Henney AM (1995) Matrix metalloproteinases and cardiovascular disease. Circ Res 77:863-868
13. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ (2001) Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 89(3):201-210
14. Moshal KS, Metreveli N, Tyagi SC (2008) Mitochondrial matrix metalloproteinase activation and dysfunction in hyperhomocysteinemia. Curr Vasc Pharmacol 6:84-92
15. Nelson KK, Melendez JA (2004) Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 37(6):768-784
16. Osterby R (1974) Early phases in the development of diabetic glomerulopathy. Acta Med Scand Suppl 574:3-82
17. Brito PL, Fioretto P, Drummond K, Kim Y, Steffes MW, Basgen JM, Sisson-Ross S, Mauer M (1998) Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int 53:754-761
18. Okada H, Inoue T, Suzuki H, Strutz F, Neilson EG (2000) Epithelialmesenchymal transformation of renal tubular epithelial cells in vitro and in vivo. Nephrol Dial Transplant 15:44-46
19. He H, Yang X, Zeng X, Shi M, Yang J, Wu L, Li L (2007) Protective effect of Liuwei Dihuang decoction on early diabetic nephropathy induced by streptozotocin via modulating ET-ROS axis and matrix metalloproteinase activity in rats. J Pharm Pharmacol 59(9):1297-1305
20. Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z (2007) Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. J Nephrol 20(4):444-452
21. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM (1989) Glomerular lesions and urinary albumin excretion rate in type 1 diabetic patients without overt proteinuria. N Engl J Med 320:966-970
22. Wang X, Shaw S, Amiri F, Eaton DC, Marrero MB (2002) Inhibition of the Jak/STAT signaling pathway prevents the high glucose induced increase in tgf-beta and fibronectin synthesis in mesangial cells. Diabetes 51:3505-3509
23. Schnaper HW, Kopp JB, Poncelet AC et al (1996) Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells. J Cell Sci 109:2521-2528
24. Ulusu NN, Turan B (2005) Beneficial effects of selenium on some enzymes of diabetic rat heart. Biol Trace Elem Res 103(3):207-216
25. Hafeman DG, Sunde RA, Hoekstra WG (1974) Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr 104(5):580-587
26. Ayaz M, Ozdemir S, Ugur M, Vassort G, Turan B (2004) Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys 426(1):83-90
27. Bilginoglu A, Kandilci B, Turan B (2013) Intracellular levels of Na(+) and TTX-sensitive Na(+) channel current in diabetic rat ventricular cardiomyocytes. Cardiovasc Toxicol 13(2):138-147. doi: 10.1007/s12012-012-9192-9
28. Cam M, Yavuz O, Guven A, Ercan F, Bukan N, Ustundag N (2003) Protective effects of chronic melatonin treatment against renal injury in streptozotocin-induced diabetic rats. J Pineal Res 35(3):212-220
29. Monnier VM, Miyata S, Nagaraj RH, Sell DR (1993) Relevance of the early and advanced Maillard reaction in diabetic neuropathy. Diabet Med 10(Suppl 2):103S-106S
30. Ha H, Kim KH (1999) Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Res Clin Pract 45(2-3):147-151
31. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC (1984) Structural-functional relationships in diabetic nephropathy. J Clin Invest 74(4):1143-1155
32. Aydemir-Koksoy A, Bilginoglu A, Sariahmetoglu M, Schulz R, Turan B (2010) Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. J Nutr Biochem 21(9):827-833
33. Suziki D, Miyata T, Saotome N, Horie K, Inagi R, Yasuda Y, Uchida K, Izuhara Y, Yagame M, Sakai H, Kurokawa K (1999) Immunohistochemical evidence for an increased oxidative stres and carbonyl modification of proteins in diabetic glomerüler lesions. J Am Soc Nephrol 10:822-832
34. Doi T, Mima A, Matsubara T, Tominaga T, Arai H, Abe H (2008) The current clinical problems for early phase of diabetic nephropathy and nephropathy and approach for pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract 8:21-24
35. Reeves WB, Andreoli TE (2000) Transforming growth factor β contributes to progressive diabetic nephropathy. PNAS 97:7667-7669
36. Bangstad HJ, Osterby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Hanssen KF (1994) Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37(5):483-490
37. Makino H, Yamasaki Y, Haramoto T, Shikata K, Hironaka K, Ota Z, Kanwar YS (1993) Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy. Lab Invest 68(1):45-55
38. Tsuchitani M, Kuroda J, Nagatani M, Miura K, Katoh T (1990) Glycogen accumulation in the renal tubular cells of spontaneously occurring diabetic WBN/Kob rats. J Comp Pathol 102:179-190
39. Mauer SM, Steffes MW, Michael AF, Brown DM (1976) Studies of diabetic nephropathy in animal and man. Diabetes 25:850-857
40. McCane KL, Huether S (1994) Pathophysiology the biologic basis for disease in adults and children. In: McCane KL (ed) Altered cellular and tissue biology. Mossby, Maryland Heights, pp 73-78
41. Kang J, Dai XS, Yu TB, Wen B, Yang Z (2005) Glycogen accumulation in renal tubules, a key morphological change in the diabetic rat kidney. Acta Diabetol 42:110-116
42. Wang Z, Jiang T, Li J, Proctor G, McManaman JL, Lucia S, Chua S, Levi M (2005) Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVB mice with type 2 diabetes. Diabetes 54:2328-2335
43. Takeji M, Moriyama T, Oseto S, Kawada N, Hori M, Imai E, Miwa T (2006) Smooth muscle α-actin deficiency in myofibroblasts leads to enhanced renal tissue fibrosis. J Biol Chem 281:40193-40200
44. Chebotareva NV, Proppe D, Rudolf P, Kozlovskaia LV (2002) Clinical significance of expression of the smooth muscle actin-alpha and CD34 antigen in mesangial cells in glomerulonephritis. Ter Arkh 74:27-31
45. Essawy M, Soylemezoglu O, Muchaneta C, Shortland J, Brown B, Nahas AM (1997) Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 12:43-50